MARIA VENTURA: Open Payments
NPI 1790811750 · MC MURRAY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,787 in 181 payments from 20 companies in 2025. Trend: 2023 $749 · 2024 $2,767 · 2025 $2,787
Food & beverage: $2,787
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $420 |
| Janssen Biotech, Inc. | 22 | $298 |
| ABBVIE INC. | 33 | $271 |
| Galderma Laboratories, L.P. | 16 | $204 |
| LEO Pharma Inc. | 14 | $199 |
| Novartis Pharmaceuticals Corporation | 7 | $174 |
| Amgen Inc. | 9 | $158 |
| Regeneron Healthcare Solutions, Inc. | 6 | $155 |
| Arcutis Biotherapeutics, Inc. | 14 | $147 |
| UCB, Inc. | 10 | $140 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, OTEZLA, NEMLUVIO, Zoryve, ADBRY, Bimzelx.
Industry payments across PA — which companies pay providers there.
